Slaven is the President and Chief Operating Officer at Multiomic Health, an AI-enabled precision medicine company, conducting research to develop therapeutic assets for metabolic syndrome.
Prior to his role at Multiomic, Slaven founded a cellular ageing biotech startup -The Longevity Labs GmbH- whose award-winning nutraceutical is now marketed in >14 countries including the US. He exited after 3 years. Slaven also held operational leadership roles at two other data-intensive startups in cancer genomics and AI-enabled robotics respectively.
Slaven was named to Forbes 30 Under 30 in 2017.